After completing the Ismaelillo clinical trial in this city and analyzing the results, the Center for State Control of Medicines, Equipment and Medical Devices (Cecmed) decided to approve the Authorization for Emergency Use of the Cuban vaccine Abdala for pediatric population in ages between 2 and 11 years. Last week the regulatory entity had authorized the use in the segment between 12 and 18 years.

This Tuesday little Keyler Brito Díaz went to the Julio Antonio Mella polyclinic in the city to put his shoulder as “Chamaquili”, where 20 children from three to eleven years old received the initial dose of Abdala. Phase one of the Ismaelillo clinical trial in this age range is carried out when boys from 12 to 18 are already in a second stage.